| J9271 | Injection, pembrolizumab, 1 mg | 9,200 | $40 | $395.6K |
| J0897 | Injection, denosumab, 1 mg | 5,160 | $20 | $98K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 910 | $90 | $84.2K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 2,200 | $20 | $37.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 360 | $90 | $34.2K |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 90 | $340 | $31.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 340 | $60 | $21.1K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 260 | $50 | $13.5K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 70 | $120 | $8.1K |
| 96417 | In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy… | 160 | $50 | $7.5K |